Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Banco Santander SA (SAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Banco Santander SA — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $44.17 (market cap $7.10B), while Banco Santander SA trades at $13.41 (market cap $196.43B). The key difference: Banco Santander SA is far larger — about 27.7× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Banco Santander SA pays a 2.16% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Banco Santander SA for 55 Days on average.
| IONS | SAN | |
|---|---|---|
Market Cap | $7.10B | $196.43B |
Volume | 2,027,457 | 9,190,091 |
Sector | Health | Financials |
52-Week High | $86.50 | $15.05 |
52-Week Low | $42.38 | $9.65 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $6.66B | $360.59B |
Dividend Yield | — | 2.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Banco Santander (SAN) trades at $13.55, up 0.52% today, with a bearish technical signal but strong fundamentals including a 26.25% net income margin and 16.07% ROE. Recent earnings show a mix of beats and misses, with Q1 2026 exceeding expectations. The company completed the Webster Financial acquisition in August 2026, expanding its U.S. presence. Cash flow trends indicate challenges, with negative net cash flow in recent years, though profitability remains robust.
The outlook is mixed: solid profitability and analyst support (64% buy ratings) contrast with bearish technicals and cash flow concerns. Key opportunities include diversification from the Webster deal and record profits, while risks involve persistent negative operating cash flow and high debt levels. Investor sentiment is cautiously optimistic amid integration execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →
